## Abstract To assess the clinical value of whole-body positron emission tomography (PET) with [18F]fluorodeoxyglucose (FDG) in recurrent colorectal cancer, 35 patients were studied: 15 had resectable liver metastases, one a resectable lung metastasis, eight resectable pelvic recurrence, eight a pr
Positron-emission tomography with [18F]fluorodeoxyglucose
β Scribed by E. K. J. Pauwels; E. J. C. Sturm; E. Bombardieri; F. J. Cleton; M. P. M. Stokkel
- Publisher
- Springer-Verlag
- Year
- 2000
- Tongue
- English
- Weight
- 181 KB
- Volume
- 126
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background. Conventional imaging is limited in identifying persistent disease after organβpreserving therapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). We studied the accuracy of positron emission tomography (PET) with ^18^Fβfluoroβ2βdeoxyβDβglu
## Abstract ## Background The aim of our study was to assess the value of positron emission tomography (PET) with 18Fβfluorodeoxyglucose (FDG) for the staging of clinically nodal negative necks in oral and oropharyngeal squamous cell carcinoma (SCC) using sentinel lymph node (SLN) biopsy and elect
was calculated, and the patients were divided into high (Β’3.0) and low (Γ΅3.0) SUV
## Background: Fluorine 18 fluorodeoxyglucose (fdg) has been shown to accumulate in inflamed tissues. however, it is not known whether vascular inflammation can be measured noninvasively. the aim of this study was to test the hypothesis that vascular inflammation can be measured noninvasively by us